Goldfish leaping between two glass bowls, water splashing.

READINESS DOSSIER

We get biotech companies ready for diligence.

Swiss life-sciences advisory, Geneva. We run the diligence on you before your next investor does.

PATTERN 01

Investors rarely say no. They say "not yet".

PATTERN 02

"Not yet" costs you runway.

REMEDY

Start with our diligence.

THE REFRAME

Investors don't buy your science. They price your risk.

Every question in diligence is the same question: what could go wrong, and do you know it before they do?

METHOD

Every investor runs diligence. Ours comes first.

01

Map

The diligence your next investor will run, at the bar of that round.

02

Fix

What breaks gets fixed, in the order that moves valuation.

03

Prove

A data room that answers before they ask.

HOW WE WORK

Five steps. We stay for all of them.

  1. 01 Map Our diligence first: the route, then what breaks.
  2. 02 Structure Entity, governance, IP, cap table.
  3. 03 Fix Science reviewed. Trials, model, plan fixed.
  4. 04 Prove Evidence in the data room, before they ask.
  5. 05 Govern Board seat, or the seat behind it.

SERVICES

Before you hire them

You'll hire a CFO and a CMO after the round. Investors test you on both before it.

Until then, you get both perspectives from us. Keeping us on as fractional CFO and CMO is an option, not a condition.

Fractional CFO

An embedded finance function: monthly close, driver-based model, investor reporting, data-room readiness.

Read more

Fractional CMO

Chief Medical Officer capacity for clinical-stage ventures.

Read more

Transaction diligence

Due diligence, data-room readiness, market intelligence.

Read more

WHO WE ARE

We have sat where your investors sit.

Portrait of Patricia Delaite, MD.

THE PHYSICIAN SCIENTIST

Patricia Delaite, MD

Oncologist. Twice a biotech CMO. Trials supporting Series A to C and an exit. Board experience: listed companies and start-ups.

in
Portrait of Jean-Marc Suter.

THE BANKER

Jean-Marc Suter

Swiss banker in Geneva, London and Abu Dhabi. Thirty years of pitches across his desk. He knows where they break.

in

Working in English and French, from Geneva.

YOUR DOSSIER: NOT YET WRITTEN

Start with our diligence, before your next investor runs theirs.